XML 63 R45.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' Equity - Additional information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 15, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Jul. 25, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation cost related to non-vested share-based compensation awards granted   $ 7,900   $ 7,900      
Unrecognized compensation cost related to non-vested share-based compensation awards granted year       2022      
Stock option exercisable   1,992,349   1,992,349      
Conversion of Series A preferred stock     47,894,000        
Antidilutive shares excluded from the computation of diluted earnings per common share   18,131,489 23,849,633 17,528,530 17,334,492    
Proceeds from issuance common stock before underwriters discounts and commissions and offering expenses $ 50,000            
Proceeds from issuance common stock net of underwriters discounts and commissions and offering expenses 47,600            
Gross proceeds to selling stockholder from public offering $ 19,000     $ 48,000      
Stock options granted to underwriters vesting period 30 days            
Common Stock, shares authorized   125,000,000   125,000,000     125,000,000
Stock issued during period, shares, new issues 12,000,000            
Sale of stock, price per share $ 5.00            
Sale of stock, number of shares issued in transaction 10,000,000            
Subsequent Event [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common Stock, shares authorized           175,000,000  
Common stock, capital shares reserved for future issuance           14,000,000  
IPO [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock options granted to underwriters number of shares in grant after underwriter expenses 1,800,000            
2011 Equity Incentive Plan [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of equity instruments awarded in period       492,198      
Restricted Stock Units (RSUs) [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of equity instruments awarded in period       360,250      
Vesting period of shares       3 years      
Fair market value of RSUs granted       $ 1,600      
Series B Preferred Stock [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Conversion of Series A preferred stock   (684)   (1,384) 5,000    
Series A preferred shares outstanding   1,716   1,716      
Series A Preferred Stock [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Conversion of Series A preferred stock       0      
Series A preferred shares outstanding   2,093,155   2,093,155      
Stock issued during period, shares, new issues       0      
Common Stock [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Conversion of Series A preferred stock   3,800,000   7,688,888      
Board of Directors and Employee [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of equity instruments awarded in period       2,134,956      
Fair market value of shares granted       $ 9,000      
Term of options granted period       10 years      
Employees [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period of shares       3 years      
Employees [Member] | Restricted Stock Units (RSUs) [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of equity instruments awarded in period       47,000      
Board of Director [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period of shares, Description       Board of Directors vest ratably through 2022